BLOG ブログ

院長のご紹介

院長 松岡 慎 SUSUMU MATSUOKA

はじめまして、院長の松岡慎です。
私は、高度に細分化された先進医療が患者さまを救うと信じて20年近く大病院に勤務してまいりました。事実、狭い分野でしたが日本の第一人者として全国を飛び回るような生活をしてきました。
しかし、専門家として患者さまの病気のごく一面のみしか診察していなかったことに物足りなさを感じるようになり、患者さまの全身を診られる医師でありたい。小さなクリニックだからこそできる患者さまの目線に立ったきめ細かな医療をしたい。この思いより、父が開業していたこの地でまつおかクリニックを再開することを思い立ちました。これが、当院のスタンスです。
まつおかクリニックは“患者さまを一病気のみにとらわれず全人的に診察する”という理念をもって設立しました。理念を大切にし、理念を実現することのためにたゆまぬ努力を続けます。
来院されたすべての方が満足できるような総合的医療を提供するために、わたしたちは医療・サービスいずれも勉強を怠らず、進化していくことをお約束します。

略歴

1965年
3月4日生
1977年
名古屋市立桜小学校 卒業
1980年
名古屋市立桜田中学校 卒業
1983年
私立東海高等学校 卒業
1991年
名古屋市立大学 卒業
1992年
中津川市民病院
1994年
岐阜県立多治見病院
2001年
名古屋第二赤十字病院
2007年
名古屋大学医学部臨床講師(兼任)
2008年
Sweden Uppsala大学 留学
2010年
まつおかクリニック院長
2014年
医療法人 マイルストーン理事長

執筆論文

  • 1.

    Matsuoka S, Tominaga Y, Sato T, Uno N, Hiramitu T, Goto N, Nagasaka T, Uchida K.; The Relationship between the Dimension of Parathyroid Glands Estimated by Ultrasonography and the Hyperplastic Pattern in Patients with Renal Hyperparathyroidism. Ther Apher Dial. 2008 12(5):391-395

  • 2.

    Matsuoka S, Uchida K, Tominaga Y, Uno N, Shimabukuro S, Goto N, Sato T, Nagasaka T.; Laparoscopic Splenectomy with Modification is Beneficial Technique for Hemodialysis Patients Who are Candidates for ABO-incompatible Living Donor Renal Transplantation. Ther Apher Dial. 2008 Oct;12(5):381-4

  • 3.

    Matsuoka S, Tominaga Y, Sato T, Uno N, Goto N, Katayama A, Uchida K, Takami H.; QuiCk-IntraOperative Bio-Intact PTH assay at parathyroidectomy for secondary hyperparathyroidism. World J Surg. 2007 Apr;31(4):824-31.

  • 4.

    Matsuoka S, Tominaga Y, Sato T, Uno N, Goto N, Katayama A, Uchida K, Tsuzuki T.; Recurrent renal hyperparathyroidism caused by parathyromatosis. World J Surg. 2007 Feb;31(2):299-305.

  • 5.

    Matsuoka S, Tominaga Y, Uno N, Goto N, Sato T, Katayama A, Uchida K, Nakao A.; Surgical significance of undescended parathyroid gland in renal hyperparathyroidism. Surgery. 2006 Jun;139(6):815-20.

  • 6.

    Matsuoka S, Tominaga Y, Uno N, Goto N, Sato T, Katayama A, Haba T, Uchida K, Kobayashi K, Nakao A.; Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism. World J Surg. 2005 May;29(5):632-5

  • 7.

    Matsuoka S;Miura; Y; Kachi T; Hattori Y; Ohno J; Oda K; Nagamura Y; Oiso Y; Humoral hypercalcemia of malignancy associated with parathyroid hormone-related protein producing transitional cell carcinoma of the ureter. Intern Med. 1994 Feb; 33(2): 107-9

  • 8.

    Tominaga Y, Matsuoka S,Uno N, Tsuzuki T, Hiramitsu T, Goto N, Nagasaka T, Watarai Y, Uchida K.Tominaga Y, et al. Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg. 2010 Jun;34(6):1312-7.

  • 9.

    Sato T, Kikkawa Y, Hiramitsu T, Yamamoto T, Goto N, Matsuoka S, Nagasaka T, Watarai Y, Uchida K, Tominaga Y.Sato T, et al. Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism. Ther Apher Dial. 2011 Jun;15 Suppl 1:26-32

  • 10.

    Sato T, Fukagawa M, Uchida K, Katayama A, Nagasaka T, Matsuoka S, Goto N, Tominaga Y, Kobayashi T, Nakao A; 1,25-dihydroxyvitamin D synthesis after renal transplantation: the role of fibroblast growth factor 23 and cyclosporine. Clin Transplant. 2009 Jun-Jul;23(3):368-74.

  • 11.

    Tominaga Y, Matsuoka S; Total parathyroidectomy with forearm autograft for secondary hyperparathyroidism due to chronic kidney disease Nippon Geka Gakkai Zasshi. 2009 Mar;110(2):96-100.

  • 12.

    Tominaga Y, Matsuoka S, Uno N; Surgical and Medical Treatment of Secondary Hyperparathyroidism in Patients on Continuous Dialysis.World J Surg. 2009 Feb 27.

  • 13.

    Nanasato M, Goto N, Isobe S, Unno K, Hirayama H, Sato T, Matsuoka S, Nagasaka T, Tominaga Y, Uchida K, Murohara T; Restored cardiac conditions and left ventricular function after parathyroidectomy in a hemodialysis patient. Parathyroidectomy improves cardiac fatty acid metabolism assessed by 123I-BMIPP. Circ J. 2009 Oct;73(10):1956-60. Epub 2009 Jan 27.

  • 14.

    Uno N, Tominaga Y, Matsuoka S, Tsuzuki T, Shimabukuro S, Sato T, Goto N, Nagasaka T, Katayama A, Uchida K.;Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism.World J Surg. 2008 Nov;32(11):2516-9.

  • 15.

    Tominaga Y, Matsuoka S, Uno N, Sato T; Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial. 2008 Oct;12 Suppl 1:S21-6.

  • 16.

    Yamashiro N, Tominaga Y, Matsuoka S,Yamashiro N, Tominaga Y, Matsuoka S, Uno N, Goto N, Sato T, Katayama A, Motoyuki H, Tsuzuki T, Uchida K.; A supernumerary parathyroid gland located in an unusual site, parapharyngeal space, in a patient with persistent renal hyperparathyroidism. Nephrol Dial Transplant. 2008 Jan;23(1):419-20.

  • 17.

    Tominaga Y, Matsuoka S, Tominaga Y, Matsuoka S, Sato T, Uno N, Goto N, Katayama A, Haba T; Kazuharu Uchida (Yagoto PTx Forum).; Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy. Ther Apher Dial. 2007 Aug;11(4):266-73.

  • 18.

    Tominaga Y, Inaguma D, Matsuoka S, Tahara H, Kukita K, Kurihara S, Onoda N, Tsuruta Y, Tsutsui S, Ohta K, Kuwahara M, Tanaka M, Nishizawa Y; PTG study group.; Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? Ther Apher Dial. 2006 Apr;10(2):198-204.

  • 19.

    Tanaka M, Tominaga Y, Itoh K, Matsushita K, Matsushita K, Matsuoka S, Ueki T, Goto N, Sato T, Katayama A, Haba T, Uchida K.; Autoinfarction of the parathyroid gland diagnosed by power Doppler ultrasonography in a patient with secondary hyperparathyroidism. Nephrol Dial Transplant. 2006 Apr;21(4):1092-5.

  • 20.

    Uno N, Tominaga Y, Sato T, Goto N, Matsuoka S, Kataoka A, Haba T, Uchida K.; Two patients with hyperparathyroidism which was progressive for more than ten years after successful kidney transplantation Clin Calcium. 2005 Sep;15 Suppl 1:51-5

  • 21.

    Tanaka M, Ito K, Matsushita K, Matsushita K, Tominaga Y, Matsuoka S, Ueki T, Goto N, Sato T, Katayama A, Haba T, Uchida K.; Usefulness of power Doppler ultrasonography for the diagnosis of autoinfarction of parathyroid gland in secondary hyperparathyroidism Clin Calcium. 2005 Sep;15 Suppl 1:46-9

  • 22.

    Goto N, Uchida K, Morozumi K, Ueki T, Matsuoka S, Katayama A, Haba T, Tominaga Y, Fukuda M, Nakao A, Kimura G.; Circadian blood pressure rhythm is disturbed by nephrectomy. Hypertens Res. 2005 Apr;28(4):301-6.

  • 23.

    Goto N, Tominaga Y, Matsuoka S, Sato T, Katayama A, Haba T, Uchida K.; Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy. Clin Exp Nephrol. 2005 Jun;9(2):138-41.

  • 24.

    Tominaga Y, Matsuoka S, Sato T.; Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial. 2005 Feb;9(1):44-7.

  • 25.

    Tanaka M, Tominaga Y, Sawatari E, Itoh K, Matsushita K, Matsushita K, Matsuoka S, Ueki T, Goto N, Sato T, Katayama A, Haba T, Uchida K.; Infarction of mediastinal parathyroid gland causing spontaneous remission of secondary hyperparathyroidism. Am J Kidney Dis. 2004 Oct;44(4):762-7.

  • 26.

    Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Uchida K, Nakanishi S, Kazama JJ, Gejyo F, Yamashita T, Fukagawa M.; Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis. 2004 Sep;44(3):481-7.

  • 27.

    Sato T, Inagaki A, Uchida K, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Tominaga Y, Okajima Y, Ohta K, Suga H, Taguchi S, Kakiya S, Itatsu T, Kobayashi T, Nakao A.; Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.Transplantation. 2003 Nov 15;76(9):1320-6.

  • 28.

    Tominaga Y, Katayama A, Sato T, Matsuoka S, Goto N, Haba T, Hibi Y, Numano M, Ichimori T, Uchida K.; Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant. 2003 Jun;18 Suppl 3:iii65-70.

  • 29.

    Katayama A; Kobayashi T; Uchida K; Goto N; Matsuoka S; Sato T; Haba T; Tominaga Y; Kohara S; Kamura H; Liu D; Yokoyama I; Oikawa T; Takeda A; Morozumi K; Takagi H; Nakao A; Beneficial effect of antibody removal and enhanced immuno suppression in flow cytometry cross match-positive and ABO-incompatible renal transplantation. Transplant Proc – 01-NOV-2002; 34(7): 2771-2

  • 30.

    Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H; Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation. Transplant Proc – 01-AUG-2002; 34(5): 1736-7

  • 31.

    Uchida K; Tominaga Y; Haba T; Katayama A; Sato T; Matsuoka S; Goto N; Kimata T; Takeda A; Morozumi K; Takagi H; Kobayashi T; Yokoyama I; Nakao A; Usefulness of two-point AUC(0-4) monitoring in maintenance renal transplant patients. Transplant Proc – 01-NOV-2001; 33(7-8): 3128-30